牛叉诊股

[{"date":"2026.06.22","stock":"0.21","trade":"-0.45","ind":"1.78"},{"date":"2026.06.18","stock":"-1.84","trade":"-0.26","ind":"-0.43"},{"date":"2026.06.17","stock":"-1.76","trade":"-1.01","ind":"0.40"},{"date":"2026.06.16","stock":"-1.85","trade":"-0.94","ind":"-0.11"},{"date":"2026.06.15","stock":"-0.48","trade":"0.19","ind":"1.61"},{"date":"2026.06.12","stock":"2.67","trade":"1.37","ind":"1.12"},{"date":"2026.06.11","stock":"-1.10","trade":"-1.40","ind":"-0.16"},{"date":"2026.06.10","stock":"0.29","trade":"-0.21","ind":"-0.42"},{"date":"2026.06.09","stock":"-0.04","trade":"-0.20","ind":"1.28"},{"date":"2026.06.08","stock":"-2.08","trade":"-2.15","ind":"-1.70"},{"date":"2026.06.05","stock":"0.72","trade":"0.78","ind":"-0.74"},{"date":"2026.06.04","stock":"-1.51","trade":"-1.51","ind":"-0.64"},{"date":"2026.06.03","stock":"-1.68","trade":"-1.25","ind":"0.22"},{"date":"2026.06.02","stock":"-1.46","trade":"-1.13","ind":"0.43"},{"date":"2026.06.01","stock":"1.52","trade":"1.32","ind":"-0.27"},{"date":"2026.05.29","stock":"3.09","trade":"1.30","ind":"-0.73"},{"date":"2026.05.28","stock":"-1.66","trade":"-0.70","ind":"0.12"},{"date":"2026.05.27","stock":"0.28","trade":"-0.49","ind":"-1.25"},{"date":"2026.05.26","stock":"-0.08","trade":"-1.00","ind":"-0.17"},{"date":"2026.05.25","stock":"0.12","trade":"-0.47","ind":"0.96"},{"date":"2026.05.22","stock":"-1.21","trade":"0.56","ind":"0.87"}]

同仁堂,上证指数,中药指数

压力支撑

该股压力位为23.24元，支撑位为22.77元。

[{"text":"\u538b\u529b\u4f4d","value":"23.24","date":1782057600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.77","date":1782057600,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：1.9资金面打败了5%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：06月22日 20:31

机构今日流向(万元)	-429.11	机构5日流向(万元)	-4364.06
机构10日流向(万元)	-5232.88	机构20日流向(万元)	-10126.80

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少6124.55万股，其中基金净减仓137家，主力净减仓88家，请投资者中长期谨慎为宜。

截止2025-12-31，共270家主力机构（基金265家，阳光私募1家，一般法人3家，保险公司1家），持仓量总计85887.89万股，占流通A股62.62%
其中，基金持仓与2025-06-30相比：
增仓：39家，增持 524.96万股
减仓：176家，减持 1074.73万股
新出现在主力名单中：37家，持有56.86万股
从主力名单中消失：125家，原持有1659.08万股

消息面诊股

诊断结果：5.8消息面打败了47%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-05-27
一般消息	募资投向	公司购买资产	2026-05-27
一般消息	高管变动	工作调整	2026-04-07
利好	分红转增	10派5元(含税)	2026-03-31
一般消息	重大事项	关联交易	2026-01-17
一般消息	重大事项	关联交易	2025-11-29
一般消息	重大事项	关联交易	2025-09-30
一般消息	分红转增	不分配不转增	2025-08-30
一般消息	高管变动	委员会调整	2025-08-11
一般消息	高管变动	取消监事会	2025-07-14
一般消息	高管变动	工作调整	2025-07-08

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：5.1行业面打败了73%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2026.06.22","price":"1.78","value":"-0.45"},{"date":"2026.06.18","price":"-0.43","value":"-0.26"},{"date":"2026.06.17","price":"0.40","value":"-1.01"},{"date":"2026.06.16","price":"-0.11","value":"-0.94"},{"date":"2026.06.15","price":"1.61","value":"0.19"},{"date":"2026.06.12","price":"1.12","value":"1.37"},{"date":"2026.06.11","price":"-0.16","value":"-1.40"},{"date":"2026.06.10","price":"-0.42","value":"-0.21"},{"date":"2026.06.09","price":"1.28","value":"-0.20"},{"date":"2026.06.08","price":"-1.70","value":"-2.15"},{"date":"2026.06.05","price":"-0.74","value":"0.78"},{"date":"2026.06.04","price":"-0.64","value":"-1.51"},{"date":"2026.06.03","price":"0.22","value":"-1.25"},{"date":"2026.06.02","price":"0.43","value":"-1.13"},{"date":"2026.06.01","price":"-0.27","value":"1.32"},{"date":"2026.05.29","price":"-0.73","value":"1.30"},{"date":"2026.05.28","price":"0.12","value":"-0.70"},{"date":"2026.05.27","price":"-1.25","value":"-0.49"},{"date":"2026.05.26","price":"-0.17","value":"-1.00"},{"date":"2026.05.25","price":"0.96","value":"-0.47"},{"date":"2026.05.22","price":"0.87","value":"0.56"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	三力制药	7.98%	3.21%	5.7分
2	华润江中	6.43%	-1.39%	5.4分
3	康惠股份	6.36%	14.58%	5.8分
4	吉林敖东	5.57%	5.75%	5.6分
5	华森制药	4.14%	9.63%	4.8分
6	维康药业	-0.18%	12.13%	5.6分
7	康恩贝	-0.96%	0.00%	5.8分
8	步长制药	-1.05%	-0.72%	5.4分
9	华润三九	-1.47%	-5.43%	5.2分
10	羚锐制药	-1.68%	-4.32%	4.8分
11	白云山	-1.79%	-2.02%	4.9分
12	以岭药业	-1.95%	-1.05%	5.6分
13	九芝堂	-2.21%	-0.38%	5.8分
14	云南白药	-2.29%	-3.83%	4.9分
15	天士力	-2.84%	-5.00%	4.7分
16	天目药业	-3.07%	11.35%	4.8分
17	佛慈制药	-4.06%	-2.66%	5.2分
18	恩威医药	-4.22%	7.82%	5.5分
19	仁和药业	-4.28%	-2.83%	5.1分
20	昆药集团	-4.74%	-6.08%	4.5分
21	康缘药业	-4.76%	-4.29%	5.0分
22	马应龙	-5.23%	-4.11%	4.6分
23	ST百灵	-5.30%	0.22%	4.8分
24	东阿阿胶	-5.80%	-10.26%	4.7分
25	千金药业	-6.18%	-2.94%	5.4分
26	亚宝药业	-6.19%	-3.75%	5.1分
27	*ST香雪	-6.34%	-0.32%	4.1分
28	同仁堂	-6.62%	-5.61%	4.2分
29	众生药业	-6.71%	-1.86%	5.7分
30	达仁堂	-7.08%	-1.33%	5.0分
31	桂林三金	-7.10%	-3.61%	4.7分
32	葵花药业	-7.13%	-3.70%	4.7分
33	佐力药业	-7.14%	-2.94%	4.8分
34	片仔癀	-7.89%	-4.41%	4.8分
35	济川药业	-8.07%	-5.05%	6.1分
36	红日药业	-8.56%	-2.61%	4.7分
37	精华制药	-8.76%	-1.85%	4.9分
38	方盛制药	-8.80%	-6.59%	5.3分
39	盘龙药业	-9.45%	-2.28%	4.1分
40	信邦制药	-9.48%	-4.48%	4.7分
41	-	-9.52%	-2.36%	分
42	特一药业	-9.58%	-1.72%	4.1分
43	奇正藏药	-9.82%	-3.49%	4.9分
44	太龙药业	-10.03%	-9.11%	4.7分
45	-	-10.48%	-5.06%	分
46	粤万年青	-11.07%	0.07%	4.1分
47	太极集团	-11.13%	-5.15%	4.9分
48	汉森制药	-11.16%	-1.17%	4.9分
49	广誉远	-11.34%	-4.61%	4.8分
50	ST万邦	-11.35%	9.73%	5.3分
51	寿仙谷	-11.46%	-10.38%	4.6分
52	古汉医药	-11.78%	-0.97%	5.3分
53	健民集团	-12.58%	2.95%	5.6分
54	中恒集团	-13.12%	-11.11%	4.0分
55	康美药业	-13.46%	-3.57%	4.2分
56	ST葫芦娃	-13.64%	-7.82%	4.8分
57	陇神戎发	-13.82%	-3.41%	4.8分
58	振东制药	-14.05%	-6.73%	3.9分
59	沃华医药	-14.43%	-3.65%	5.3分
60	华神科技	-14.85%	-2.65%	4.9分
61	益佰制药	-16.13%	-5.17%	4.7分
62	益盛药业	-16.28%	-4.42%	4.9分
63	新光药业	-16.92%	-3.99%	4.3分
64	新天药业	-17.06%	-4.31%	4.1分
65	ST嘉应	-19.70%	-10.80%	4.5分
66	ST金花	-20.77%	-5.02%	4.8分
67	上海凯宝	-22.77%	-4.93%	3.6分
68	珍宝岛	-35.25%	-17.33%	4.7分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.7基本面打败了43%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（70分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/107 ， 53/107。

[{"date":"2026-03-31","value":"3.40","vol":"2.21"},{"date":"2025-12-31","value":"8.86","vol":"-2.33"},{"date":"2025-09-30","value":"8.77","vol":"4.80"},{"date":"2025-06-30","value":"7.10","vol":"4.03"},{"date":"2025-03-31","value":"4.32","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	3.40	8.86	8.77	7.10	4.32
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"41.66","vol":"55.05"},{"date":"2025-12-31","value":"42.87","vol":"52.85"},{"date":"2025-09-30","value":"43.86","vol":"53.29"},{"date":"2025-06-30","value":"44.29","vol":"53.82"},{"date":"2025-03-31","value":"45.51","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	41.66	42.87	43.86	44.29	45.51
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 45/107 ， 50/107。

[{"date":"2026-03-31","value":"-11.59","vol":"-5.58"},{"date":"2025-12-31","value":"-7.21","vol":"-6.76"},{"date":"2025-09-30","value":"-3.70","vol":"-7.84"},{"date":"2025-06-30","value":"0.06","vol":"-7.78"},{"date":"2025-03-31","value":"0.16","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	-11.59	-7.21	-3.70	0.06	0.16
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"-19.07","vol":"1.06"},{"date":"2025-12-31","value":"-22.07","vol":"-80.25"},{"date":"2025-09-30","value":"-12.78","vol":"-2.78"},{"date":"2025-06-30","value":"-7.39","vol":"2.25"},{"date":"2025-03-31","value":"1.10","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	-19.07	-22.07	-12.78	-7.39	1.10
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 20/107 ， 56/107。

[{"date":"2026-03-31","value":"0.15","vol":"0.12"},{"date":"2025-12-31","value":"0.56","vol":"0.47"},{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.31","vol":"0.24"},{"date":"2025-03-31","value":"0.17","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.15	0.56	0.42	0.31	0.17
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.27","vol":"0.59"},{"date":"2025-12-31","value":"0.92","vol":"2.34"},{"date":"2025-09-30","value":"0.68","vol":"1.72"},{"date":"2025-06-30","value":"0.50","vol":"1.17"},{"date":"2025-03-31","value":"0.27","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.27	0.92	0.68	0.50	0.27
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"20.21","vol":"5.83"},{"date":"2025-12-31","value":"17.86","vol":"30.77"},{"date":"2025-09-30","value":"0.98","vol":"10.53"},{"date":"2025-06-30","value":"24.94","vol":"22.82"},{"date":"2025-03-31","value":"15.78","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	20.21	17.86	0.98	24.94	15.78
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.32","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.27","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.32	-	0.27	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/107 ， 44/107。

[{"date":"2026-03-31","value":"3.77","vol":"2.97"},{"date":"2025-12-31","value":"3.59","vol":"2.94"},{"date":"2025-09-30","value":"3.45","vol":"3.09"},{"date":"2025-06-30","value":"3.30","vol":"2.94"},{"date":"2025-03-31","value":"3.45","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	3.77	3.59	3.45	3.30	3.45
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.17","vol":"2.23"},{"date":"2025-12-31","value":"1.89","vol":"2.15"},{"date":"2025-09-30","value":"1.82","vol":"2.24"},{"date":"2025-06-30","value":"1.77","vol":"2.15"},{"date":"2025-03-31","value":"1.87","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.17	1.89	1.82	1.77	1.87
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 26/107 ， 21/107。

[{"date":"2026-03-31","value":"29.34","vol":"31.94"},{"date":"2025-12-31","value":"30.18","vol":"32.43"},{"date":"2025-09-30","value":"32.57","vol":"31.59"},{"date":"2025-06-30","value":"33.70","vol":"32.45"},{"date":"2025-03-31","value":"32.65","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	29.34	30.18	32.57	33.70	32.65
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.65","vol":"0.66"},{"date":"2025-12-31","value":"0.68","vol":"0.67"},{"date":"2025-09-30","value":"0.76","vol":"0.76"},{"date":"2025-06-30","value":"0.80","vol":"0.75"},{"date":"2025-03-31","value":"0.77","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.65	0.68	0.76	0.80	0.77
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
国泰海通证券	2026-05-17	买入
华创证券	2026-05-15	增持
长城证券	2026-04-30	增持
华兴证券	2026-04-17	增持
华泰证券	2026-04-11	买入	买入
光大证券	2026-04-06	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"14.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"16.69","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.26","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"11.89","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"13.69","blueLineValue":"1.00","type":"YC"}]

[同仁堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]